Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 137Carcinoma, Non-Small-Cell Lung 38Carcinoma, Renal Cell 33Neoplasm Metastasis 32Prostatic Neoplasms 22Brain Neoplasms 21Lung Neoplasms 20Pancreatic Neoplasms 19Uveal Melanoma 17Neoplasms 17Carcinoma, Hepatocellular 13Breast Neoplasms 13Sarcoma 12Skin Neoplasms 10Kidney Neoplasms 10Urinary Bladder Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Glioblastoma 9Triple Negative Breast Neoplasms 8Ovarian Neoplasms 8Colorectal Neoplasms 8Carcinoma, Transitional Cell 8Small Cell Lung Carcinoma 7Multiple Myeloma 7Colonic Neoplasms 7Clear-cell metastatic renal cell carcinoma 7Recurrence 6Myelodysplastic Syndromes 6Diabetes Mellitus, Insulin-Dependent, 12 6Uterine Cervical Neoplasms 5

Interventions

Radiotherapy 24Radiotherapy, Intensity-Modulated 8Radiosurgery 6Amifostine 5Low-Level Light Therapy 4Donepezil 4Cisplatin 4Carboplatin 4Surveys and Questionnaires 3Radiation 3Proton Therapy 3Paclitaxel 3Neuropsychological Tests 3Heavy Ion Radiotherapy 3Etoposide 3Chemotherapy, Adjuvant 3Chemoradiotherapy 3Brachytherapy 3Bevacizumab 3Surgical Procedures, Operative 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Mental Status and Dementia Tests 2Esophagectomy 2Androgen Antagonists 2Adrenal Cortex Hormones 2sodium propionate 1sargramostim 1olaparib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Injuries × Ipilimumab × Clear all
NCT02406183 2017-01-10

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

University Hospital, Ghent

Phase 1 Completed
13 enrolled
Dermatologic

Melanoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡